Trials / Conditions / Persistent Cervical Cancer
Persistent Cervical Cancer
3 registered clinical trials studyying Persistent Cervical Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With NCT07472153 | N.N. Alexandrov National Cancer Centre | Phase 2 / Phase 3 |
| Unknown | First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cance NCT04974944 | Sun Yat-sen University | Phase 2 |
| Terminated | Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer NCT04230954 | University of South Alabama | Phase 2 |